Brooks O'Neil
Stock Analyst at Lake Street
(0.59)
# 4,138
Out of 5,124 analysts
34
Total ratings
26.47%
Success rate
-20.54%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFMD LifeMD | Maintains: Buy | $14 → $8 | $3.41 | +134.60% | 4 | Nov 18, 2025 | |
| TNDM Tandem Diabetes Care | Downgrades: Hold | $75 → $12 | $21.98 | -45.40% | 2 | Aug 11, 2025 | |
| RCEL AVITA Medical | Maintains: Buy | $14 → $8 | $3.45 | +131.88% | 7 | Aug 11, 2025 | |
| PIII P3 Health Partners | Maintains: Buy | $50 → $20 | $3.49 | +473.07% | 2 | Apr 21, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $81.10 | +35.64% | 2 | Feb 28, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $30 | $30.47 | -1.54% | 1 | Feb 24, 2025 | |
| SMLR Semler Scientific | Maintains: Buy | $40 → $71 | $15.29 | +364.36% | 1 | Jan 24, 2025 | |
| LFVN LifeVantage | Initiates: Buy | $26 | $6.16 | +322.08% | 1 | Dec 19, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $55 | $49.00 | +12.24% | 3 | Oct 4, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $32 → $18 | $21.04 | -14.45% | 4 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $20 | $8.72 | +129.36% | 1 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $5.18 | -3.47% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $6.77 | +77.25% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $26 | $29.12 | -10.71% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $0.36 | +2,921.15% | 1 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $128 | $29.84 | +327.28% | 1 | Sep 15, 2020 |
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $3.41
Upside: +134.60%
Tandem Diabetes Care
Aug 11, 2025
Downgrades: Hold
Price Target: $75 → $12
Current: $21.98
Upside: -45.40%
AVITA Medical
Aug 11, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $3.45
Upside: +131.88%
P3 Health Partners
Apr 21, 2025
Maintains: Buy
Price Target: $50 → $20
Current: $3.49
Upside: +473.07%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $81.10
Upside: +35.64%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $30
Current: $30.47
Upside: -1.54%
Semler Scientific
Jan 24, 2025
Maintains: Buy
Price Target: $40 → $71
Current: $15.29
Upside: +364.36%
LifeVantage
Dec 19, 2024
Initiates: Buy
Price Target: $26
Current: $6.16
Upside: +322.08%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $49.00
Upside: +12.24%
Alphatec Holdings
Sep 3, 2024
Maintains: Buy
Price Target: $32 → $18
Current: $21.04
Upside: -14.45%
Aug 9, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $8.72
Upside: +129.36%
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $5.18
Upside: -3.47%
Mar 7, 2024
Initiates: Buy
Price Target: $12
Current: $6.77
Upside: +77.25%
Feb 15, 2023
Maintains: Buy
Price Target: $20 → $26
Current: $29.12
Upside: -10.71%
Apr 8, 2022
Initiates: Buy
Price Target: $11
Current: $0.36
Upside: +2,921.15%
Sep 15, 2020
Initiates: Buy
Price Target: $128
Current: $29.84
Upside: +327.28%